363 related articles for article (PubMed ID: 19291518)
1. Update on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosis.
Koenig W
Ann Med; 2009; 41(5):332-43. PubMed ID: 19291518
[TBL] [Abstract][Full Text] [Related]
2. Integrating biomarkers: the new frontier?
Koenig W
Scand J Clin Lab Invest Suppl; 2010; 242():117-23. PubMed ID: 20515289
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease.
Herder C; Karakas M; Koenig W
Clin Pharmacol Ther; 2011 Jul; 90(1):52-66. PubMed ID: 21654741
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers for atherosclerosis: pathophysiological role and pharmacological modulation.
Ferri N; Paoletti R; Corsini A
Curr Opin Lipidol; 2006 Oct; 17(5):495-501. PubMed ID: 16960497
[TBL] [Abstract][Full Text] [Related]
5. Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men.
Tuomainen AM; Nyyssönen K; Laukkanen JA; Tervahartiala T; Tuomainen TP; Salonen JT; Sorsa T; Pussinen PJ
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2722-8. PubMed ID: 17932311
[TBL] [Abstract][Full Text] [Related]
6. Biobanks and the search for predictive biomarkers of local and systemic outcome in atherosclerotic disease.
Hurks R; Peeters W; Derksen WJ; Hellings WE; Hoefer IE; Moll FL; de Kleijn DP; Pasterkamp G
Thromb Haemost; 2009 Jan; 101(1):48-54. PubMed ID: 19132188
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers for cardiovascular disease: challenges and future directions.
May A; Wang TJ
Trends Mol Med; 2008 Jun; 14(6):261-7. PubMed ID: 18487087
[TBL] [Abstract][Full Text] [Related]
8. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
[TBL] [Abstract][Full Text] [Related]
9. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
Corson MA; Jones PH; Davidson MH
Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein: a nontraditional serum marker of cardiovascular risk.
de Ferranti SD; Rifai N
Cardiovasc Pathol; 2007; 16(1):14-21. PubMed ID: 17218210
[TBL] [Abstract][Full Text] [Related]
11. Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease.
Fraley AE; Tsimikas S
Curr Opin Lipidol; 2006 Oct; 17(5):502-9. PubMed ID: 16960498
[TBL] [Abstract][Full Text] [Related]
12. [What are the biomarkers of atherosclerosis and cardiovascular risk?].
Riesen WF
Rev Med Suisse; 2008 Mar; 4(148):636-8, 640-3. PubMed ID: 18459658
[TBL] [Abstract][Full Text] [Related]
13. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
Nordestgaard BG; Zacho J
Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857
[TBL] [Abstract][Full Text] [Related]
14. Does fibrinogen add to prediction of cardiovascular disease? Results from the Scottish Heart Health Extended Cohort Study.
Woodward M; Tunstall-Pedoe H; Rumley A; Lowe GD
Br J Haematol; 2009 Aug; 146(4):442-6. PubMed ID: 19549268
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory biomarkers and cardiovascular risk: association or cause and effect?
Rao M; Jaber BL; Balakrishnan VS
Semin Dial; 2006; 19(2):129-35. PubMed ID: 16551290
[TBL] [Abstract][Full Text] [Related]
16. Novel antecedent plasma biomarkers of cardiovascular disease: improved evaluation methods and comparator benchmarks raise the bar.
Welsh P; Packard CJ; Sattar N
Curr Opin Lipidol; 2008 Dec; 19(6):563-71. PubMed ID: 18957878
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease.
Roberts MA; Hare DL; Ratnaike S; Ierino FL
Am J Kidney Dis; 2006 Sep; 48(3):341-60. PubMed ID: 16931208
[TBL] [Abstract][Full Text] [Related]
18. Assessment of inflammatory markers and endothelial function.
Järvisalo MJ; Juonala M; Raitakari OT
Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):547-52. PubMed ID: 16912549
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive assessment of cardiovascular risk: from Framingham to the future.
Vogel RA; Benitez RM
Rev Cardiovasc Med; 2000; 1(1):34-42. PubMed ID: 12457150
[TBL] [Abstract][Full Text] [Related]
20. [Inflammation and C-reactive protein in cardiovascular disease].
Munk PS; Larsen AI
Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
